To evaluate the probe's targeting efficacy towards NRP1 in vivo, we selected MDA-MB-231, HCT116, and NCI-H1299 tumor-bearing mouse models, each representing different levels of NRP1 and GLUT1 expression. Here, SLC2A1 is linked to neoplasm.